Corline Biomedical AB (CLBIO) — Net Asset Quality Index
Corline Biomedical AB (CLBIO) has a Net Asset Quality Index of 95.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr98.58 Million minus total liabilities of Skr4.82 Million yields net assets of Skr93.76 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Corline Biomedical AB (CLBIO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Corline Biomedical AB Net Asset Quality Index Over Time (2012–2025)
This chart shows how Corline Biomedical AB's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 95.1%, representing net assets of Skr93.76 Million against total assets of Skr98.58 Million SEK. See how liquid is Corline Biomedical AB's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Corline Biomedical AB (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Corline Biomedical AB from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Corline Biomedical AB stock valuation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | Skr93.76 Million | Skr98.58 Million | Skr4.82 Million | ▲ +3.4 pp |
| 2024 | 91.7% | Skr86.91 Million | Skr94.76 Million | Skr7.85 Million | ▼ -1.5 pp |
| 2023 | 93.2% | Skr93.32 Million | Skr100.11 Million | Skr6.79 Million | ▲ +0.3 pp |
| 2022 | 92.9% | Skr94.59 Million | Skr101.78 Million | Skr7.19 Million | ▲ +2.2 pp |
| 2021 | 90.7% | Skr92.23 Million | Skr101.66 Million | Skr9.43 Million | ▲ +1.5 pp |
| 2020 | 89.3% | Skr52.03 Million | Skr58.28 Million | Skr6.25 Million | ▼ -3.8 pp |
| 2019 | 93.0% | Skr59.32 Million | Skr63.75 Million | Skr4.43 Million | ▲ +5.7 pp |
| 2018 | 87.4% | Skr54.96 Million | Skr62.91 Million | Skr7.95 Million | ▼ -1.9 pp |
| 2017 | 89.3% | Skr45.93 Million | Skr51.43 Million | Skr5.50 Million | ▼ -4.6 pp |
| 2016 | 93.9% | Skr38.75 Million | Skr41.27 Million | Skr2.53 Million | ▲ +8.9 pp |
| 2015 | 85.0% | Skr21.25 Million | Skr24.99 Million | Skr3.74 Million | ▲ +52.3 pp |
| 2014 | 32.7% | Skr5.48 Million | Skr16.77 Million | Skr11.29 Million | ▼ -25.4 pp |
| 2013 | 58.1% | Skr8.00 Million | Skr13.76 Million | Skr5.76 Million | ▲ +47.1 pp |
| 2012 | 11.0% | Skr1.37 Million | Skr12.46 Million | Skr11.09 Million | — |